Navigation Links
Shoreline Biome Announces International Distribution Partnership in Japan
Date:1/7/2020

Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization.

TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food development.

The partnership will introduce Shoreline Biome's products to a wider Asian market and is expected to support the growth of the Japanese microbiome market. The human microbiome market in the Asia Pacific region is expected to reach $207.81 million USD in 2025, an increase from $41.73 million USD in 2017, according to a 2019 report from ResearchAndMarkets.com . The same report estimates the market to grow with a CAGR of 22.8% from 2018—2025.

TOMY has been a distribution partner with Pacific Biosciences (PacBio), a company that provides genomic analysis systems, since 2011. There is valuable synergy between Shoreline Biome products and PacBio's platform, according to Bill McKenzie, Shoreline Biome's CEO.

“We're very excited about this partnership,” said McKenzie. "TOMY is a recognized leader in providing biotechnology products like Shoreline Biome's to Asian markets, and we couldn't be more pleased to offer our products to this growing market. Having our products under the same distribution roof as PacBio's is nothing but advantageous to users of both company's products in this market.

McKenzie is optimistic about the value of Shoreline Biome's products to the Asian market.

"Our all-in-one kits and software accelerate breakthroughs in microbiome research," he said. "Ultimately, this leads to a better understanding of how our microbiomes relate to human health and disease.”

A detailed list of Shoreline Biome’s international distributors and ordering information by country can be accessed at shorelinebiome.com/international-distributors.

About Shoreline Biome:
Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

Read the full story at https://www.prweb.com/releases/shoreline_biome_announces_international_distribution_partnership_in_japan/prweb16813341.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine news :

1. Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre
2. 5 Seconds of Summer Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes 5 SOS Tickets in Mountain View at Shoreline Amphitheatre
3. Animal, human health benefits anticipated from universitys premier biomedical instrument
4. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Filing of Biomet Hip Replacement Class Action Lawsuit in Canada
5. Biomet Hip Lawsuit News: Rottenstein Law Group LLP Discusses Canadian M2A Magnum Class Action
6. California Healthcare Institute to Release 2014 California Biomedical Industry Report
7. Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Parties’ Submission of Bellwether Trial Proposals in Federal Biomet Hip Replacement Litigation
8. Dr. Peter Bassett, Dental Implants Dentist in Tempe, AZ Introduces Biomet 3i Dental Implants for Faster, More Successful Implant Procedures
9. New materials with potential biomedical applications
10. CHI and PwC US Release 2014 California Biomedical Industry Report
11. Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... Secours Mercy Health Our Lady of Bellefonte Hospital (OLBH) achieved a 59 percent ... goal established by the Centers for Disease Control and Prevention. , The retrospective ...
(Date:1/23/2020)... ... January 23, 2020 , ... The Mount Sinai Health System has once again ... , Mount Sinai was ranked No. 3 in the “Healthcare & Social” category and ... is New York City’s largest academic medical system, including eight hospitals, a leading medical ...
(Date:1/23/2020)... ... 2020 , ... Worldwide Business with kathy ireland® is pleased to ... Vice President of Dairy and Frozen, Jimmy Farber to discuss their healthy, affordable all ... food and snack options at an affordable price. The company believes that the best ...
(Date:1/23/2020)... ... January 23, 2020 , ... Merger and acquisition activity in the ... of 2019, according to data from HealthCareMandA.com. The total is the lowest reported in ... when 65 deals were announced. , One deal disclosed a price in the fourth ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... services for organizations that operate vehicle fleets in North America and around the ... will be published monthly with content accessible on the company’s website. , Developed ...
Breaking Medicine News(10 mins):
(Date:1/23/2020)... NEW YORK (PRWEB) , ... January 23, 2020 ... ... spectrum disorder (ASD) to date, researchers have identified 102 genes associated with risk ... associated with ASD from those associated with intellectual disability and developmental delay, conditions ...
(Date:1/23/2020)... ... January 23, 2020 , ... For ... Australian Dream® for effective relief. Now, the company is unveiling new packaging ... sought to develop a new design that better communicates the quality and benefits ...
(Date:1/23/2020)... ... January 23, 2020 , ... EBSCO ... announced the availability of a new decision aid within its shared decision making ... to manage opioid addiction. , Opioid addiction is a chronic relapsing condition of ...
Breaking Medicine Technology: